On Wednesday shares of Crestwood Midstream Partners LP (NYSE:CMLP) closed at $15.31. Company’s sales growth for last 5 years was 96.50% and EPS growth for next 5 years is recorded as -0.90%. Houston’s Crestwood Equity Partners LP and Crestwood Midstream Partners LP (NYSE:CMLP) are merging into a single entity worth roughly $7.5 billion, the two master limited partnerships said Wednesday, in a consolidation the energy companies believe will enhance their overall value.
salesforce.com, inc. (NYSE:CRM) in last trading activity increased 1.43% to close at $73.79. Company weekly performance is -1.15% while its quarterly performance stands at 25.09%. salesforce.com, inc. (NYSE:CRM) is -5.95% away from its 52 week high. On 4 May, salesforce.com, inc. (NYSE:CRM) announced that for the fifth consecutive year, Salesforce Service Cloud is positioned by Gartner, Inc. in the “Leaders” quadrant of the 2015 CRM Customer Engagement Center report. The evaluation is based on completeness of vision and ability to execute.
On last trading day Pfizer Inc. (NYSE:PFE) decreased -1.93% to close at $33.46. Its volatility for the week is 1.45% while volatility for the month is 1.43%. PFE’s sales growth for past 5 years was 0.10% and its EPS growth for past 5 years was 3.10%. Pfizer Inc. (NYSE:PFE) monthly performance is -3.13%. Pfizer Inc. (NYSE:PFE) announced two key appointments Wednesday: Michael D. Ehlers as head of research and development for its BioTherapeutics unit and John Lin as chief scientific officer of its Rinat division.
AECOM (NYSE:ACM) has 0.50% insider ownership while its institutional ownership stands at 88.30%. In last trading activity company’s stock closed at $31.14. Aecom (NYSE:ACM) Omansaid it has won a contract from Duqm Development Company (DDC) to develop the masterplan and detail design for the second phase of its residential community Duqm Frontier Town.
On last trading day Pain Therapeutics Inc. (NASDAQ:PTIE) increased 0.51% to close at $1.97. Its volatility for the week is 3.97% while volatility for the month is 4.12%. PTIE’s EPS growth for past 5 years was -27.50%. Pain Therapeutics Inc. (NASDAQ:PTIE) monthly performance is 3.68%. On 30 April, Pain Therapeutics Inc. (NASDAQ:PTIE) has stated that it is focused on an orderly transition of the program back from Pfizer, which they expect to be substantially complete in the second quarter of 2015, finalizing a strategy around the prospect of resubmitting the NDA, and seeking a new commercial partner.